Worthing, United Kingdom

John D Allen

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John D Allen. Retrieved from https://idiyas.com/inventor/john-d-allen-hrakqfd7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John D Allen

Introduction

John D Allen is a notable inventor based in Worthing, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on hybrid .alpha.-interferon. His research has led to the development of a stable aqueous solution that is crucial for medical applications.

Latest Patents

John D Allen holds 1 patent for his invention titled "Pharmaceutical compositions comprising hybrid .alpha.-interferon." This patent provides a stable aqueous solution of hybrid .alpha.-interferon, which contains a stabilizer in the form of a buffer with a pH ranging from 3.0 to 5.0. This innovation is essential for enhancing the stability and efficacy of pharmaceutical formulations.

Career Highlights

Throughout his career, John D Allen has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has contributed to advancements in drug formulations and therapeutic applications.

Collaborations

John has collaborated with notable colleagues, including Nicholas Lowther and Colin Howes. Their combined expertise has fostered a productive environment for innovation and research.

Conclusion

John D Allen's contributions to pharmaceutical sciences exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…